Article
CD248(TEM1/CD164L1/Endosialin): A new molecular target for anti-angiogenic therapy in Pancreatic ductal adenocarcinoma
2021-03-18
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Pancreatic ductal adenocarcinoma (PDCA) is one of the malignant tumors with the worst prognosis with a 5-year survival rate of <1%, which is known as the "king of cancers". At present, there is a lack of effective early diagnosis and treatment plan for pancreatic cancer. Therefore, there is an urgent need to understand the molecular mechanisms of pancreatic canc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 62ed9171-ae83-5cf1-96bf-bfbfd0ca1d46
- DOI
- 10.21203/rs.3.rs-217476/v1
